Entrada Therapeutics, Inc.Entrada Therapeutics, Inc.Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

No trades
See on Supercharts

TRDA fundamentals

An in-depth look to Entrada Therapeutics, Inc. operating, investing, and financing activities

TRDA free cash flow for Q3 24 is -24.91 M USD. For 2023, TRDA free cash flow was 134.19 M USD and operating cash flow was 139.8 M USD.

Q3 '20
Q1 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '20
Q1 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth